EcoDrugPlus

Matrix Metallopeptidase 3

Ensembl ID : ENSBBBG00000008782
Gene Symbol: MMP3
3 Cross references
502 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSBBBG00000017885
Gene Symbol: MMP7
3 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSBBBG00000017757
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSBBBG00000012314
Gene Symbol: MMP9
3 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSBBBG00000021879
Gene Symbol: MTOR
3 Cross references
224 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSBBBG00000004068
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSBBBG00000025338
Gene Symbol: MC3R
3 Cross references
137 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSBBBG00000020030
Gene Symbol: MC4R
3 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSBBBG00000003051
Gene Symbol: MTNR1A
3 Cross references
216 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSBBBG00000015170
Gene Symbol: MME
3 Cross references
234 Possible Orthologues:

Membrane Primary Amine Oxidase

Ensembl ID : ENSBBBG00000011564
Gene Symbol: LOC104990420
2 Cross references
304 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSBBBG00000018346
Gene Symbol: METAP2
3 Cross references
230 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).